Gerresheimer invests in Portal’s needle-free drug delivery

Jun 14, 2022

handshake

Gerresheimer has signed up to support development of Portal Instruments’ needle-free drug delivery platform, taking a stake in its new partner and agreeing to throw its weight behind a technology that has attracted the attention of Takeda.

Source: Gerresheimer invests in Portal’s needle-free drug delivery | Fierce Pharma

Hire with SEC


Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Pin It on Pinterest